Huei-Jiun Yang Selected Research

WK175

7/2010

A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huei-Jiun Yang Research Topics

Disease

5	Neoplasms (Cancer) 07/2010 - 03/2008
2	Urinary Bladder Neoplasms (Bladder Cancer) 07/2010 - 01/2009
2	Communicable Diseases (Infectious Diseases) 06/2008 - 03/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012
1	Lung Neoplasms (Lung Cancer) 01/2009

Drug/Important Bio-Agent (IBA)

4	DNA VaccinesIBA 01/2009 - 03/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2009 - 03/2008
2	Therapeutic UsesIBA 01/2009 - 01/2009
1	LipidsIBA 01/2012
1	WK175IBA 07/2010
1	N- (4- (1- benzoylpiperidin- 4- yl)butyl)- 3- (pyridin- 3- yl)acrylamideIBA 07/2010
1	NAD (NADH)IBA 07/2010
1	Niacinamide (Nicotinamide)FDA LinkGeneric 07/2010
1	TransferasesIBA 07/2010
1	AntigensIBA 01/2009
1	Tyrosine Kinase InhibitorsIBA 01/2009
1	ErbB Receptors (EGF Receptor)IBA 01/2009
1	Gefitinib (Iressa)FDA Link 01/2009
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2009
1	Small Interfering RNA (siRNA)IBA 01/2009
1	A-Form DNA (A-DNA)IBA 06/2008
1	VaccinesIBA 06/2008
1	GoldIBA 06/2008
1	Toll-Like Receptor 4IBA 03/2008
1	EndotoxinsIBA 03/2008

Therapy/Procedure

1	Therapeutics 01/2009